Lotus Pharmaceutical (Taiwan) Market Value
| 1795 Stock | TWD 279.50 3.50 1.24% |
| Symbol | Lotus |
Lotus Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lotus Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lotus Pharmaceutical.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Lotus Pharmaceutical on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Lotus Pharmaceutical Co or generate 0.0% return on investment in Lotus Pharmaceutical over 30 days. Lotus Pharmaceutical is related to or competes with Center Laboratories, Synmosa Biopharma, Handa Pharmaceuticals, DV Biomed, GeneFerm Biotechnology, Alar Pharmaceuticals, and LIWANLI Innovation. Lotus Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells medicines in Taiwan, Korea, the United Stat... More
Lotus Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lotus Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lotus Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.61 | |||
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 10.92 | |||
| Value At Risk | (2.70) | |||
| Potential Upside | 3.38 |
Lotus Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lotus Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lotus Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Lotus Pharmaceutical historical prices to predict the future Lotus Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0166 | |||
| Jensen Alpha | 7.0E-4 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | (0.06) | |||
| Treynor Ratio | 0.1255 |
Lotus Pharmaceutical Backtested Returns
Lotus Pharmaceutical has Sharpe Ratio of -0.0111, which conveys that the firm had a -0.0111% return per unit of risk over the last 3 months. Lotus Pharmaceutical exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lotus Pharmaceutical's Downside Deviation of 1.61, risk adjusted performance of 0.0166, and Mean Deviation of 1.41 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.14, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Lotus Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Lotus Pharmaceutical is expected to be smaller as well. At this point, Lotus Pharmaceutical has a negative expected return of -0.0226%. Please make sure to verify Lotus Pharmaceutical's standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if Lotus Pharmaceutical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.17 |
Very weak predictability
Lotus Pharmaceutical Co has very weak predictability. Overlapping area represents the amount of predictability between Lotus Pharmaceutical time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lotus Pharmaceutical price movement. The serial correlation of 0.17 indicates that over 17.0% of current Lotus Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 9.63 |
Lotus Pharmaceutical lagged returns against current returns
Autocorrelation, which is Lotus Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lotus Pharmaceutical's stock expected returns. We can calculate the autocorrelation of Lotus Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Lotus Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lotus Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lotus Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lotus Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lotus Pharmaceutical stock over time.
Current vs Lagged Prices |
| Timeline |
Lotus Pharmaceutical Lagged Returns
When evaluating Lotus Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lotus Pharmaceutical stock have on its future price. Lotus Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lotus Pharmaceutical autocorrelation shows the relationship between Lotus Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in Lotus Pharmaceutical Co.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lotus Stock Analysis
When running Lotus Pharmaceutical's price analysis, check to measure Lotus Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceutical is operating at the current time. Most of Lotus Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceutical's price. Additionally, you may evaluate how the addition of Lotus Pharmaceutical to your portfolios can decrease your overall portfolio volatility.